These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2882924)

  • 21. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study.
    Bonhomme N; Cador M; Stinus L; Le Moal M; Spampinato U
    Brain Res; 1995 Mar; 675(1-2):215-23. PubMed ID: 7796132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA
    Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradoxical response to dopamine agonists in tardive dyskinesia.
    Carroll BJ; Curtis GC; Kokmen E
    Am J Psychiatry; 1977 Jul; 134(7):785-9. PubMed ID: 17308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine.
    Barrett RL; Appel JB
    Psychopharmacology (Berl); 1989; 99(1):13-6. PubMed ID: 2528777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sucrose sham-feeding in the rat after administration of the selective dopamine D2 receptor agonist N-0437, d-amphetamine or cocaine.
    Cooper SJ; Rusk IN; Barber DJ
    Pharmacol Biochem Behav; 1989 Feb; 32(2):447-52. PubMed ID: 2567016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of apomorphine to induce dopamine receptor hypersensitivity.
    Flemenbaum A
    Psychopharmacology (Berl); 1979 Apr; 62(2):175-9. PubMed ID: 111281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of amosulalol, a novel combined alpha- and beta-adrenoreceptor antagonist, on the rat isolated right ventricle and aorta.
    Hughes EW; Doggrell SA
    J Auton Pharmacol; 1985 Sep; 5(3):169-76. PubMed ID: 2865263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine blocks D-amphetamine-induced excitation of dopamine neurons in the ventral tegmental area.
    Shi WX; Zhang XY; Pun CL; Bunney BS
    Neuropsychopharmacology; 2007 Sep; 32(9):1922-8. PubMed ID: 17299514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catecholamine sulfates: end products or metabolic intermediates?
    Demassieux S; Bordeleau L; Gravel D; Carrière S
    Life Sci; 1987 Jan; 40(2):183-91. PubMed ID: 3796219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Octopamine and experience-dependent modulation of aggression in crickets.
    Stevenson PA; Dyakonova V; Rillich J; Schildberger K
    J Neurosci; 2005 Feb; 25(6):1431-41. PubMed ID: 15703397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a novel octopamine receptor expressed in the surf clam Spisula solidissima.
    Blais V; Bounif N; Dubé F
    Gen Comp Endocrinol; 2010 Jun; 167(2):215-27. PubMed ID: 20302871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evidence for a dendritic release of dopamine in the cat substantia nigra.
    Chéramy A; Nieoullon A; Glowinski J
    Appl Neurophysiol; 1979; 42(1-2):57-9. PubMed ID: 453805
    [No Abstract]   [Full Text] [Related]  

  • 36. Amphetamine attenuates the stimulated release of dopamine in vivo.
    Kuhr WG; Ewing AG; Near JA; Wightman RM
    J Pharmacol Exp Ther; 1985 Feb; 232(2):388-94. PubMed ID: 3968641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benztropine-induced release of dopamine from brain in vivo.
    Goodale DB; Moore KE
    Neuropharmacology; 1975 Aug; 14(8):585-9. PubMed ID: 1178116
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of dexamphetamine-induced compulsive gnawing--including the possible involvement of presynaptic alpha-adrenoreceptors.
    Thomas KV; Handley SL
    Psychopharmacology (Berl); 1978 Jan; 56(1):61-7. PubMed ID: 203967
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
    Carey RJ
    Biol Psychiatry; 1986 Mar; 21(3):317-21. PubMed ID: 3081055
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses.
    Andrews CD; Fernando JC; Curzon G
    Neuropharmacology; 1982 Jan; 21(1):63-8. PubMed ID: 6801538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.